hypercalcemia
HYPERCALCEMIA
Hypercalcemia is having serum calcium level of >10.5 mg/dL (>2.5 mmol/L).
Mild hypercalcemia is usually asymptomatic. While, more severe hypercalcemia has a constellation of clinical manifestations commonly described as "bones, abdominal moans, stones & groans."
Etiologies may be parathyroid-dependent or parathyroid independent.
Surgery is the treatment of choice for hypercalcemic patients with classic symptoms or complications of primary hyperparathyroidism.

Hypercalcemia Diagnosis

Diagnosis

Confirm hypercalcemia

  • Measure total serum Ca & ionized Ca at least twice

History

Obtain detailed history, physical exam, review prior routine chemistry results

  • Inquire about:
    • Past kidney stones
    • Fractures
    • Weight loss
    • Bone pain
    • Fatigue
    • Vitamin & mineral ingestion
    • Lithium or thiazide diuretic use

Laboratory Tests

Measure Serum Parathyroid Hormone (PTH)

  • Immunoassays specific for intact molecules using double antibody is preferred (intact parathyroid hormone)
  • Diagnosis: Elevated or inappropriately normal serum parathyroid w/ hypercalcemia usually indicates primary hyperparathyroidism
    • Exceptions: Familial hypocalciuric hypercalcemia (FHH), autonomous parathyroid secretion & rarely ectopic malignant neoplasm
  • Diagnosis: Low-undetectable serum parathyroid hormone suggests parathyroid-independent hypercalcemia
    • Evaluate patient for malignancy (many times, malignancy will already be known)
    • If malignancy is not present, search for unusual causes of hypercalcemia

Measure 24-hr urinary calcium & creatinine (Cr) excretion

  • In patients w/ familial hypocalciuric hypercalcemia, the urinary Ca excretion is low
  • Calculation of the Ca/Cr clearance ratio is believed to be preferable in diagnosing familial hypocalciuric hypercalcemia
    • The ratio is calculated from the results of 24-hour urine collection & simultaneously measured total serum Ca & Cr concentrations using the below formula: Ca/Cr clearance ratio = [24-hr urine CA x serum Cr] / [Serum CA x 24-hr urine Cr]
    • A ratio of <0.01 usually indicates familial hypocalciuric hypercalcemia, while a ratio of >0.02 is present in patients w/ hyperparathyroidism
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.